167 related articles for article (PubMed ID: 30084698)
1. Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: A Mixed-Method Analysis.
Austad K; Chary A; Xocop SM; Messmer S; King N; Carlson L; Rohloff P
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084698
[TBL] [Abstract][Full Text] [Related]
2. Loss to Follow-Up and the Care Cascade for Cervical Cancer Care in Rural Guatemala: A Cross-Sectional Study.
Garcia A; Juarez M; Sacuj N; Tzurec E; Larson K; Miller A; Rohloff P
JCO Glob Oncol; 2022 Feb; 8():e2100286. PubMed ID: 35113733
[TBL] [Abstract][Full Text] [Related]
3. Barriers to cervical cancer screening in Guatemala: a quantitative analysis using data from the Guatemala Demographic and Health Surveys.
Gottschlich A; Ochoa P; Rivera-Andrade A; Alvarez CS; Mendoza Montano C; Camel C; Meza R
Int J Public Health; 2020 Mar; 65(2):217-226. PubMed ID: 31838575
[TBL] [Abstract][Full Text] [Related]
4. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer knowledge and barriers and facilitators to screening among women in two rural communities in Guatemala: a qualitative study.
Bevilacqua KG; Gottschlich A; Murchland AR; Alvarez CS; Rivera-Andrade A; Meza R
BMC Womens Health; 2022 May; 22(1):197. PubMed ID: 35643497
[TBL] [Abstract][Full Text] [Related]
6. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
7. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
9. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
10. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
11. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
[TBL] [Abstract][Full Text] [Related]
12. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
13. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Care Continuum in South India: Evidence from a Community-based Screening Program.
Vidhubala E; Niraimathi K; Shewade HD; Mahadevan S
J Epidemiol Glob Health; 2020 Mar; 10(1):28-35. PubMed ID: 32175707
[TBL] [Abstract][Full Text] [Related]
15. Major challenges to scale up of visual inspection-based cervical cancer prevention programs: the experience of Guatemalan NGOs.
Chary AN; Rohloff PJ
Glob Health Sci Pract; 2014 Aug; 2(3):307-17. PubMed ID: 25276590
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of Cervical Cancer Screening in Rural Guatemala.
Bassette E; Mabachi N; Kennedy M; Mendez-Puac F
Hisp Health Care Int; 2022 Jun; 20(2):156-163. PubMed ID: 34467792
[TBL] [Abstract][Full Text] [Related]
17. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
18. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
19. "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
Datchoua Moukam AM; Embolo Owono MS; Kenfack B; Vassilakos P; Petignat P; Sormani J; Schmidt NC
Reprod Health; 2021 Jul; 18(1):147. PubMed ID: 34243778
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
